(Q38073684)

28 August 2017

1 reference

title

F18-FDG-PET/CT for evaluation of intraductal papillary mucinous neoplasms (IPMN): a review of the literature (English)

1 reference

28 August 2017

2

1 reference

28 August 2017

Francesco Bertagna

1

1 reference

28 August 2017

Gian Luca Baiocchi

series ordinal

3

1 reference

28 August 2017

Raffaele Giubbini

series ordinal

4

1 reference

28 August 2017

language of work or name

1 reference

12 January 2013

1 reference

Japanese journal of radiology

28 August 2017

published in

1 reference

28 August 2017

volume

31

1 reference

28 August 2017

issue

4

1 reference

28 August 2017

page(s)

229-236

1 reference

Primary cystic neoplasms of the pancreas. Neoplastic disorders of emerging importance-current state-of-the-art and unanswered questions

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Primary pancreatic cystic neoplasms revisited. Part III. Intraductal papillary mucinous neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Cystic lesions and intraductal neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Incidence, prevalence, and management of intraductal papillary mucinous neoplasm in Olmsted County, Minnesota, 1984-2005: a population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

21 January 2018

PET scanning in oncology

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Whole-body FDG-PET imaging in the management of patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

FDG PET/CT findings in malignant intraductal papillary mucinous neoplasm of the bile ducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Positron emission tomography with 2-deoxy-2-[(18)F] fluoro- d-glucose for diagnosis of intraductal papillary mucinous tumor of the pancreas with parenchymal invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Searching for indicators of malignancy in pancreatic intraductal papillary mucinous neoplasms: the value of 18FDG-PET confirmed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Comparison of International Consensus Guidelines versus 18-FDG PET in detecting malignancy of intraductal papillary mucinous neoplasms of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

The Utility of F-18 FDG PET/CT in the Evaluation of Pancreatic Intraductal Papillary Mucinous Neoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

18F-FDG PET findings and GLUT-1 expression in IPMNs of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Positron-emission tomography and computed tomography of cystic pancreatic masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

F-18-fluorodeoxyglucose positron emission tomography in differentiating malignant from benign pancreatic cysts: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Value of 18-fluorodeoxyglucose positron emission tomography in the management of patients with cystic tumors of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

International consensus guidelines for surgical resection of mucinous neoplasms cannot be applied to all cystic lesions of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11604-012-0176-2

Intraductal oncocytic papillary neoplasm of the pancreas: a radio-pathological case study

21 January 2018

1 reference

12 December 2020

Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas

1 reference

12 December 2020

Intraductal oncocytic papillary neoplasm of the pancreas with strong accumulation on FDG-PET.

1 reference

12 December 2020

Extracranial head and neck: PET imaging with 2-[F-18]fluoro-2-deoxy-D-glucose and MR imaging correlation

1 reference

12 December 2020

F-18 FDG uptake in borderline intraductal papillary neoplasms of the bile duct

1 reference

12 December 2020

Comparison of resected and non-resected intraductal papillary mucinous neoplasms of the pancreas

1 reference

12 December 2020

The applications of PET in clinical oncology

1 reference

12 December 2020

Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients

1 reference

12 December 2020

Positron emission tomography with 2-deoxy-2-[18f] fluoro-D-glucose in the detection of malignancy in intraductal papillary mucinous neoplasms of the pancreas

1 reference

12 December 2020

Mucin-producing tumor of the pancreas: natural history and serial pancreatogram changes

1 reference

12 December 2020

Intraductal papillary mucinous neoplasm-the tip of the iceberg.

1 reference

12 December 2020

10.1007/S11604-012-0176-2

Identifiers

DOI

1 reference

Dimensions Publication ID

28 August 2017

1011494354

0 references

1 reference